NACC1 and melanoma: To test if the modulation of NAC1 could significantly alter the activity of the NF-κB pathway, B16 mouse melanoma cells were subjected to vector-based RNAi to deplete NAC1, and the siRNA-mediated down-regulation of NAC1 was examined using a quantitative real-time PCR and Western blot (Figure 1A).